questionsmedicales.fr
Composés hétérocycliques
Composés hétérocycliques à cycles fusionnés
Composés hétérobicycliques
Benzopyranes
Coumarines
4-Hydroxycoumarines
4-Hydroxycoumarines : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Temps de prothrombine
INR
Symptômes
5
Effets secondaires
Nausées
Réaction allergique
Éruption cutanée
Prévention
5
Précautions
Anticoagulants
Éducation des patients
Anticoagulants
Interactions médicamenteuses
Consultation
Traitements
5
Interactions médicamenteuses
Anticoagulants
Anticoagulants
Alternatives
Complications
5
Facteurs de risque
Anticoagulants
Facteurs de risque
5
Facteurs de risque
Thrombose
Antécédents médicaux
Coagulation
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "4-Hydroxycoumarines : Questions médicales les plus fréquentes",
"headline": "4-Hydroxycoumarines : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les 4-Hydroxycoumarines : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-10",
"dateModified": "2025-04-04",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "4-Hydroxycoumarines"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Coumarines",
"url": "https://questionsmedicales.fr/mesh/D003374",
"about": {
"@type": "MedicalCondition",
"name": "Coumarines",
"code": {
"@type": "MedicalCode",
"code": "D003374",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.150.446"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Acénocoumarol",
"alternateName": "Acenocoumarol",
"url": "https://questionsmedicales.fr/mesh/D000074",
"about": {
"@type": "MedicalCondition",
"name": "Acénocoumarol",
"code": {
"@type": "MedicalCode",
"code": "D000074",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.150.446.520.079"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Dicoumarol",
"alternateName": "Dicumarol",
"url": "https://questionsmedicales.fr/mesh/D001728",
"about": {
"@type": "MedicalCondition",
"name": "Dicoumarol",
"code": {
"@type": "MedicalCode",
"code": "D001728",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.150.446.520.203"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Biscoumacétate d'éthyle",
"alternateName": "Ethyl Biscoumacetate",
"url": "https://questionsmedicales.fr/mesh/D005017",
"about": {
"@type": "MedicalCondition",
"name": "Biscoumacétate d'éthyle",
"code": {
"@type": "MedicalCode",
"code": "D005017",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.150.446.520.451"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Phenprocoumone",
"alternateName": "Phenprocoumon",
"url": "https://questionsmedicales.fr/mesh/D010644",
"about": {
"@type": "MedicalCondition",
"name": "Phenprocoumone",
"code": {
"@type": "MedicalCode",
"code": "D010644",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.150.446.520.750"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Warfarine",
"alternateName": "Warfarin",
"url": "https://questionsmedicales.fr/mesh/D014859",
"about": {
"@type": "MedicalCondition",
"name": "Warfarine",
"code": {
"@type": "MedicalCode",
"code": "D014859",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.150.446.520.914"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "4-Hydroxycoumarines",
"alternateName": "4-Hydroxycoumarins",
"code": {
"@type": "MedicalCode",
"code": "D015110",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Li Sheng",
"url": "https://questionsmedicales.fr/author/Li%20Sheng",
"affiliation": {
"@type": "Organization",
"name": "Department of Drug Metabolism, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P. R. China."
}
},
{
"@type": "Person",
"name": "Zahra Hosseini-Khah",
"url": "https://questionsmedicales.fr/author/Zahra%20Hosseini-Khah",
"affiliation": {
"@type": "Organization",
"name": "Diabetes Research Center, Mazandaran University of Medical Sciences, Sari, Iran."
}
},
{
"@type": "Person",
"name": "Saeed Emami",
"url": "https://questionsmedicales.fr/author/Saeed%20Emami",
"affiliation": {
"@type": "Organization",
"name": "Department of Medicinal Chemistry and Pharmaceutical Sciences Research Center, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran. sdemami12@gmail.com."
}
},
{
"@type": "Person",
"name": "Jhonnathan Brawley",
"url": "https://questionsmedicales.fr/author/Jhonnathan%20Brawley",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, University of Nevada, Reno, Nevada 89557-0216, United States."
}
},
{
"@type": "Person",
"name": "Amarawan Intasiri",
"url": "https://questionsmedicales.fr/author/Amarawan%20Intasiri",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, University of Nevada, Reno, Nevada 89557-0216, United States."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Behavioral Addictive Disorders in Children and Adolescents.",
"datePublished": "2022-08-22",
"url": "https://questionsmedicales.fr/article/36007819",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jaac.2022.07.819"
}
},
{
"@type": "ScholarlyArticle",
"name": "Risk Factors for Addictive Behaviors: A General Overview.",
"datePublished": "2022-05-28",
"url": "https://questionsmedicales.fr/article/35682170",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijerph19116583"
}
},
{
"@type": "ScholarlyArticle",
"name": "Nosology of behavioral addictions: Intersections with philosophy of psychiatry •.",
"datePublished": "2022-07-13",
"url": "https://questionsmedicales.fr/article/35895455",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1556/2006.2022.00033"
}
},
{
"@type": "ScholarlyArticle",
"name": "Internet-based interventions for behavioral addictions: A systematic review.",
"datePublished": "2022-08-04",
"url": "https://questionsmedicales.fr/article/36495471",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1556/2006.2022.00054"
}
},
{
"@type": "ScholarlyArticle",
"name": "Substance and Behavioral Addictions, and Their Consequences among Vulnerable Populations.",
"datePublished": "2022-05-19",
"url": "https://questionsmedicales.fr/article/35627700",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijerph19106163"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés hétérocycliques",
"item": "https://questionsmedicales.fr/mesh/D006571"
},
{
"@type": "ListItem",
"position": 3,
"name": "Composés hétérocycliques à cycles fusionnés",
"item": "https://questionsmedicales.fr/mesh/D000072471"
},
{
"@type": "ListItem",
"position": 4,
"name": "Composés hétérobicycliques",
"item": "https://questionsmedicales.fr/mesh/D006574"
},
{
"@type": "ListItem",
"position": 5,
"name": "Benzopyranes",
"item": "https://questionsmedicales.fr/mesh/D001578"
},
{
"@type": "ListItem",
"position": 6,
"name": "Coumarines",
"item": "https://questionsmedicales.fr/mesh/D003374"
},
{
"@type": "ListItem",
"position": 7,
"name": "4-Hydroxycoumarines",
"item": "https://questionsmedicales.fr/mesh/D015110"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : 4-Hydroxycoumarines - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur 4-Hydroxycoumarines",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-13",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur 4-Hydroxycoumarines",
"description": "Comment diagnostiquer une surdose de 4-hydroxycoumarines ?\nQuels tests sont utilisés pour surveiller le traitement par 4-hydroxycoumarines ?\nQuels symptômes indiquent une complication du traitement ?\nComment évaluer l'efficacité des 4-hydroxycoumarines ?\nQuels signes cliniques nécessitent une évaluation urgente ?",
"url": "https://questionsmedicales.fr/mesh/D015110?mesh_terms=Behavior,+Addictive#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur 4-Hydroxycoumarines",
"description": "Quels sont les effets secondaires courants des 4-hydroxycoumarines ?\nComment reconnaître une réaction allergique aux 4-hydroxycoumarines ?\nQuels symptômes peuvent indiquer une thrombose malgré le traitement ?\nQuels signes indiquent une surdose de 4-hydroxycoumarines ?\nQuels symptômes nécessitent un ajustement de la dose ?",
"url": "https://questionsmedicales.fr/mesh/D015110?mesh_terms=Behavior,+Addictive#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur 4-Hydroxycoumarines",
"description": "Comment prévenir les complications des 4-hydroxycoumarines ?\nQuelles précautions prendre lors de l'utilisation de 4-hydroxycoumarines ?\nComment éduquer les patients sur les 4-hydroxycoumarines ?\nQuels aliments éviter avec les 4-hydroxycoumarines ?\nComment gérer les interactions médicamenteuses ?",
"url": "https://questionsmedicales.fr/mesh/D015110?mesh_terms=Behavior,+Addictive#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur 4-Hydroxycoumarines",
"description": "Comment traiter une surdose de 4-hydroxycoumarines ?\nQuels médicaments interagissent avec les 4-hydroxycoumarines ?\nQuelle est l'alternative aux 4-hydroxycoumarines ?\nComment ajuster la dose de 4-hydroxycoumarines ?\nQuels sont les traitements de soutien lors d'une surdose ?",
"url": "https://questionsmedicales.fr/mesh/D015110?mesh_terms=Behavior,+Addictive#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur 4-Hydroxycoumarines",
"description": "Quelles sont les complications possibles des 4-hydroxycoumarines ?\nComment gérer une hémorragie due aux 4-hydroxycoumarines ?\nQuels facteurs augmentent le risque de complications ?\nComment prévenir les thromboses sous traitement ?\nQuels signes indiquent une complication grave ?",
"url": "https://questionsmedicales.fr/mesh/D015110?mesh_terms=Behavior,+Addictive#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur 4-Hydroxycoumarines",
"description": "Quels sont les facteurs de risque pour les complications des 4-hydroxycoumarines ?\nComment l'alimentation influence-t-elle l'efficacité des 4-hydroxycoumarines ?\nQuels médicaments augmentent le risque de saignement ?\nComment l'âge affecte-t-il le traitement par 4-hydroxycoumarines ?\nQuels antécédents médicaux sont préoccupants ?",
"url": "https://questionsmedicales.fr/mesh/D015110?mesh_terms=Behavior,+Addictive#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une surdose de 4-hydroxycoumarines ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests de coagulation et l'évaluation des symptômes cliniques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour surveiller le traitement par 4-hydroxycoumarines ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le temps de prothrombine (TP) et l'INR sont les tests principaux pour surveiller l'efficacité."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une complication du traitement ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des saignements inhabituels, des ecchymoses ou des douleurs abdominales peuvent indiquer une complication."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'efficacité des 4-hydroxycoumarines ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'efficacité est évaluée par la réduction des événements thromboemboliques et les résultats des tests de coagulation."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques nécessitent une évaluation urgente ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes de saignement grave, comme des hémorragies cérébrales ou gastro-intestinales, nécessitent une évaluation urgente."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires courants des 4-hydroxycoumarines ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires incluent des saignements, des nausées et des douleurs abdominales."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une réaction allergique aux 4-hydroxycoumarines ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des éruptions cutanées, des démangeaisons ou un gonflement peuvent indiquer une réaction allergique."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer une thrombose malgré le traitement ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs, un gonflement ou une rougeur dans une jambe peuvent indiquer une thrombose persistante."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une surdose de 4-hydroxycoumarines ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des saignements excessifs, des ecchymoses et des douleurs abdominales peuvent indiquer une surdose."
}
},
{
"@type": "Question",
"name": "Quels symptômes nécessitent un ajustement de la dose ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des saignements fréquents ou des résultats d'INR élevés peuvent nécessiter un ajustement de la dose."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications des 4-hydroxycoumarines ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une surveillance régulière de l'INR et une éducation des patients sont essentielles pour prévenir les complications."
}
},
{
"@type": "Question",
"name": "Quelles précautions prendre lors de l'utilisation de 4-hydroxycoumarines ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les activités à risque de blessure et informer les professionnels de santé de l'utilisation."
}
},
{
"@type": "Question",
"name": "Comment éduquer les patients sur les 4-hydroxycoumarines ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Informer sur les effets secondaires, l'importance des tests de coagulation et les signes d'alerte."
}
},
{
"@type": "Question",
"name": "Quels aliments éviter avec les 4-hydroxycoumarines ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les aliments riches en vitamine K, comme les légumes à feuilles vertes, pour maintenir l'efficacité."
}
},
{
"@type": "Question",
"name": "Comment gérer les interactions médicamenteuses ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Consulter un professionnel de santé avant de prendre d'autres médicaments pour éviter les interactions."
}
},
{
"@type": "Question",
"name": "Comment traiter une surdose de 4-hydroxycoumarines ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement inclut l'administration de vitamine K et la surveillance des paramètres de coagulation."
}
},
{
"@type": "Question",
"name": "Quels médicaments interagissent avec les 4-hydroxycoumarines ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des antibiotiques, des anti-inflammatoires et certains antifongiques peuvent interagir avec ces anticoagulants."
}
},
{
"@type": "Question",
"name": "Quelle est l'alternative aux 4-hydroxycoumarines ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les anticoagulants directs comme le rivaroxaban ou l'apixaban sont des alternatives possibles."
}
},
{
"@type": "Question",
"name": "Comment ajuster la dose de 4-hydroxycoumarines ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "La dose est ajustée en fonction des résultats de l'INR et des facteurs de risque individuels."
}
},
{
"@type": "Question",
"name": "Quels sont les traitements de soutien lors d'une surdose ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des transfusions de plaquettes et des soins intensifs peuvent être nécessaires en cas de surdose sévère."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles des 4-hydroxycoumarines ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des hémorragies, des thromboses et des réactions allergiques."
}
},
{
"@type": "Question",
"name": "Comment gérer une hémorragie due aux 4-hydroxycoumarines ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion inclut l'arrêt du médicament, l'administration de vitamine K et des soins médicaux appropriés."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de complications ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge avancé, les maladies hépatiques et l'utilisation concomitante d'autres anticoagulants augmentent le risque."
}
},
{
"@type": "Question",
"name": "Comment prévenir les thromboses sous traitement ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Maintenir un suivi régulier et ajuster la dose en fonction des résultats de l'INR pour prévenir les thromboses."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une complication grave ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs thoraciques, des difficultés respiratoires ou des saignements importants indiquent une complication grave."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les complications des 4-hydroxycoumarines ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents de thrombose, l'âge avancé et les maladies hépatiques sont des facteurs de risque."
}
},
{
"@type": "Question",
"name": "Comment l'alimentation influence-t-elle l'efficacité des 4-hydroxycoumarines ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation riche en vitamine K peut réduire l'efficacité des 4-hydroxycoumarines."
}
},
{
"@type": "Question",
"name": "Quels médicaments augmentent le risque de saignement ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les anti-inflammatoires non stéroïdiens (AINS) et certains antibiotiques peuvent augmenter le risque de saignement."
}
},
{
"@type": "Question",
"name": "Comment l'âge affecte-t-il le traitement par 4-hydroxycoumarines ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes âgées peuvent avoir une sensibilité accrue et nécessiter un ajustement de la dose."
}
},
{
"@type": "Question",
"name": "Quels antécédents médicaux sont préoccupants ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des antécédents de maladies hépatiques ou de troubles de la coagulation sont préoccupants lors du traitement."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 04/04/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
Department of Drug Metabolism, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P. R. China.
Beijing Key Laboratory of Non-Clinical Drug Metabolism and PK/PD Study, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P. R. China.
Publications dans "4-Hydroxycoumarines" :
2 publications dans cette catégorie
Affiliations :
Diabetes Research Center, Mazandaran University of Medical Sciences, Sari, Iran.
Publications dans "4-Hydroxycoumarines" :
2 publications dans cette catégorie
Affiliations :
Department of Medicinal Chemistry and Pharmaceutical Sciences Research Center, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran. sdemami12@gmail.com.
Publications dans "4-Hydroxycoumarines" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, University of Nevada, Reno, Nevada 89557-0216, United States.
Publications dans "4-Hydroxycoumarines" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, University of Nevada, Reno, Nevada 89557-0216, United States.
Department of Chemistry, Faculty of Science, Chulalongkorn University, Bangkok 10330, Thailand.
Publications dans "4-Hydroxycoumarines" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, University of Nevada, Reno, Nevada 89557-0216, United States.
Publications dans "4-Hydroxycoumarines" :
2 publications dans cette catégorie
Affiliations :
Department of Science, University of Kragujevac, Institute of Information Technologies, Jovana Cvijica bb, 34000 Kragujevac, Serbia.
Faculty of Science, University of Kragujevac, Radoja Domanovića 12, 34000 Kragujevac, Serbia.
Publications dans "4-Hydroxycoumarines" :
2 publications dans cette catégorie
Affiliations :
Department of Physiology and Pharmacology "Vittorio Erspamer", Sapienza University of Rome, Piazzale Aldo Moro 5, 00185 Roma, Italy.
Publications dans "4-Hydroxycoumarines" :
2 publications dans cette catégorie
Affiliations :
Faculty of Physical Chemistry, University of Belgrade, Studenski trg 12-16, 11000 Belgrade, Serbia.
Publications dans "4-Hydroxycoumarines" :
2 publications dans cette catégorie
Affiliations :
Department of Science, University of Kragujevac, Institute of Information Technologies, Jovana Cvijica bb, 34000 Kragujevac, Serbia.
Publications dans "4-Hydroxycoumarines" :
2 publications dans cette catégorie
Affiliations :
Institute of Biopharmaceutical Research, Liaocheng University, Liaocheng 252059, PR China; Shandong Provincial Key Laboratory of Chemical Energy Storage and Novel Cell Technology, Liaocheng University, Liaocheng 252059, PR China.
Publications dans "4-Hydroxycoumarines" :
2 publications dans cette catégorie
Affiliations :
Institute of Biopharmaceutical Research, Liaocheng University, Liaocheng 252059, PR China.
Publications dans "4-Hydroxycoumarines" :
2 publications dans cette catégorie
Affiliations :
Institute of Biopharmaceutical Research, Liaocheng University, Liaocheng 252059, PR China. Electronic address: lywqp@126.com.
Publications dans "4-Hydroxycoumarines" :
2 publications dans cette catégorie
Affiliations :
Institute of Biopharmaceutical Research, Liaocheng University, Liaocheng 252059, PR China.
Publications dans "4-Hydroxycoumarines" :
2 publications dans cette catégorie
Affiliations :
Institute of Biopharmaceutical Research, Liaocheng University, Liaocheng 252059, PR China.
Publications dans "4-Hydroxycoumarines" :
2 publications dans cette catégorie
Affiliations :
Institute of Biopharmaceutical Research, Liaocheng University, Liaocheng 252059, PR China; Shandong Provincial Key Laboratory of Chemical Energy Storage and Novel Cell Technology, Liaocheng University, Liaocheng 252059, PR China. Electronic address: lidacheng62@163.com.
Publications dans "4-Hydroxycoumarines" :
2 publications dans cette catégorie
Affiliations :
Institute of Biopharmaceutical Research, Liaocheng University, Liaocheng 252059, PR China.
Publications dans "4-Hydroxycoumarines" :
2 publications dans cette catégorie
Affiliations :
Institute of Biopharmaceutical Research, Liaocheng University, Liaocheng 252059, PR China.
Publications dans "4-Hydroxycoumarines" :
2 publications dans cette catégorie
Affiliations :
State Key Laboratory for Managing Biotic and Chemical Threats to the Quality and Safety of Agro-products, Ningbo University, Ningbo, Zhejiang 315211, China.
Laboratory of Biochemistry and Molecular Biology, School of Marine Sciences, Meishan Campus, Ningbo University, Ningbo, Zhejiang 315832, China.
Key Laboratory of Applied Marine Biotechnology of Ministry of Education, Meishan Campus, Ningbo University, Ningbo, Zhejiang 315832, China.
Publications dans "4-Hydroxycoumarines" :
2 publications dans cette catégorie
Affiliations :
School of Chemistry & Chemical Engineering, Zhoukou Normal University, Zhoukou, Henan 466001, China.
Publications dans "4-Hydroxycoumarines" :
Behavioral addictive disorders (BADs) are syndromes similar to substance use disorders (SUDs) but with a focus on behaviors rather than on use of psychoactive substances. These non-substance-related d...
Many people around the world have behaviors that are recognized as addictive behaviors, usually not causing significant health consequences except in a few cases, which consist typically of a low perc...
Writing in this journal, Brand and colleagues have proposed criteria for other specified disorders due to addictive behaviors. Their proposal intersects with key debates in philosophy of psychiatry, i...
Behavioral addictions are a public health problem that causes harm to both individuals and society. Internet-based interventions offer potential benefits over face-to-face therapy for the treatment of...
A systematic literature search was conducted in: PubMed, PsycINFO, Embase, and the Cochrane Central Register of Controlled Trials. A standardized methodological quality assessment was performed on all...
Twenty-nine studies were assessed in this systematic review. Between them, considerable heterogeneity was noted in various study characteristics, including screening tools, inclusion criteria, and out...
Internet-based interventions seem promising at reducing gambling problems, but too few studies have been published, to date, for conclusions to be drawn for other behavioral addictions. Internet-based...
"Vulnerable populations" in health behavior research, practice and policy is generally used to refer to groups that, due to their life circumstances, may require extra consideration, reasonable accomm...
Binge-watching (BW) refers to a pattern of watching TV series characterized by the consecutive viewing of three or more episodes in one sitting. Although there is some evidence about its effects on me...
Eating disorders (EDs) are mental health diseases characterized by dysfunctional eating patterns, including restrictive eating, avoidance of foods, binge eating, and compensative behaviors to avoid we...
As the opioid epidemic presents an ever-expanding public health threat, there is a growing need to identify effective new treatments for opioid use disorder (OUD). OUD is characterized by a behavioral...
It has been claimed that smartphone usage constitutes a behavioral addiction, characterised by compulsive, excessive use of one's phone and psychological withdrawal or distress when the phone is absen...
This study examined the degree to which perceptions of familial and household participation in gambling and other addictive behaviors in youth was associated with frequency and problem severity of gam...
The study measured perceived frequency of gambling, alcohol use, drug use and other potentially addictive behaviors in family/household members and the frequency and problem severity of gambling, alco...
About 23.45 % of participants reported their father gambled when they were a child or adolescent, followed by mother (13.56 %), grandfather (9.73 %), or grandmother (7.83 %). A pathway model demonstra...
Findings demonstrate the complex contributions of specific family and household members in the transmission of addictive behaviors. Frequency of gambling, alcohol use, and drug use mediated the relati...